Kwok-Leung Cheung of the University of Nottingham discusses his highlights from the American Society of Clinical Oncology 2021 conference, specifically focusing on the data released on hormone receptor-positive, human epidermal receptor 2-negative breast cancer.

This podcast is published open access in Oncology and Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-021-00164-2. All conflicts of interest can be found online.

This podcast is intended for medical professionals only.

This podcast has been developed independently through an unrestricted educational grant by Novartis.

Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.